Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Captopril measurement |
Component |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fetal captopril/enalapril syndrome |
Causative agent (attribute) |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril allergy |
Causative agent (attribute) |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril 50 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely captopril 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely captopril 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril + hydrochlorothiazide 50mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-zidocapt 25mg/12.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-zidocapt 50mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-zidocapt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing captopril and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-zidocapt 25mg/12.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-zidocapt 50mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Captopril adverse reaction |
Causative agent (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Non-allergic hypersensitivity to captopril (finding) |
Causative agent (attribute) |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Non-allergic hypersensitivity to captopril (finding) |
Causative agent (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely captopril 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg oral tablet |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg oral tablet |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely captopril 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing captopril and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
False |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 50 mg and hydrochlorothiazide 25 mg oral tablet |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only captopril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril and hydrochlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril and hydrochlorothiazide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only captopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Captopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |